Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000 and the Fund has a lifespan of six years.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2004 | Alveolus | Series B | 0 |
5/2010 | Nanobiotix | Series C | 0 |
10/2008 | Orteq | Series B | 14M |
3/2007 | GlucoLight | Series C | 2M |
9/2010 | Arterial Remodeling Technologies | Venture Round | 8.5M |
6/2007 | Gentis | Series A | 10M |
11/2007 | Arterial Remodeling Technologies | Venture Round | 8M |
10/2007 | AirInSpace | Series B | 0 |
7/2010 | Gentis | Venture Round | 548.3k |
9/2010 | Arterial Remodeling Technologies | Venture Round | 0 |
7/2010 | Gentis | Venture Round | 0 |
5/2010 | Nanobiotix | Series C | 0 |
10/2008 | Orteq | Series B | 0 |
11/2007 | Arterial Remodeling Technologies | Venture Round | 0 |
10/2007 | AirInSpace | Series B | 0 |
6/2007 | Gentis | Series A | 0 |
3/2007 | GlucoLight | Series C | 0 |
7/2004 | Alveolus | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|